Home

Jenburkt Pharmaceuticals PE Ratio

Image

Jenburkt Pharmaceuticals Ltd

NSE: JENBURKTPHARMA

PE

14.6

Last updated on: May 02, 2025

Key Highlights

  • The P/E Ratio of Jenburkt Pharmaceuticals Ltd is 14.6 as of 02 May 9.00 AM .
  • The P/E Ratio of Jenburkt Pharmaceuticals Ltd changed from 9.8 on March 2020 to 11.7 on March 2024 . This represents a CAGR of 3.61% over 5 years.
  • The Latest Trading Price of Jenburkt Pharmaceuticals Ltd is ₹ 1038 as of 30 Apr 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 39.9 in 5 years. This represents a CAGR of 13.70%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.1. The PE Ratio of Pharmaceuticals industry is 39.9. The PE Ratio of Retail industry is 159.2. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Jenburkt Pharmaceuticals Ltd

No data available

Company Fundamentals for Jenburkt Pharmaceuticals Ltd

Image

Jenburkt Pharmaceuticals Ltd

NSE: JENBURKTPHARMA

Share Price

₹ 1038.4

5.65 (0.55%)

stock direction

Last updated on: Apr 30, 2025

Market Price of Jenburkt Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Jenburkt Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
30 Apr 20251038.4
29 Apr 20251032.75
28 Apr 20251033.3
25 Apr 20251060.15
24 Apr 20251079.3
23 Apr 20251089
22 Apr 20251108.05
21 Apr 20251093.25
17 Apr 20251124.7
16 Apr 20251133.45

SWOT Analysis Of Jenburkt Pharmaceuticals Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Jenburkt Pharmaceuticals Ltd

Asset Value vs Market Value of Jenburkt Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Jenburkt Pharmaceuticals Ltd458.28
Sun Pharmaceutical Industries Ltd439126
Divis Laboratories Ltd161568
Cipla Ltd125156
Torrent Pharmaceuticals Ltd112171
Mankind Pharma Ltd101647

PE Ratio of Jenburkt Pharmaceuticals Ltd Explained

458.28

Market cap

31

Earnings

14.6X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Jenburkt Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in %

About Jenburkt Pharmaceuticals Ltd

  • Jenburkt Pharmaceuticals Ltd, incorporated in 1985, was formed a venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family.
  • The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products. Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries.
  • It has more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe.
  • The organisation caters to government, semi-government institutions, missionary hospitals, public sector enterprises, etc. Apart from this. the Company operate manufacturing plant at Sihor-Gujarat, approved as per W.H.O (World Health Organisation) guidelines with current Good Manufacturing Practices (GMP) requirements.

Jenburkt Pharmaceuticals Ltd News Hub

Jenburkt Pharmaceuticals to announce Quarterly Result

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 November

Read more

29 Oct 24

Jenburkt Pharmaceuticals standalone net profit rises 31.15% in the September 2024 quarter

Net profit of Jenburkt Pharmaceuticals rose 31.15% to Rs 9.60 crore in the quarter ended September 2

Read more

05 Nov 24

Jenburkt Pharmaceuticals to table results

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 January

Read more

21 Jan 25

Jenburkt Pharmaceuticals standalone net profit rises 20.56% in the December 2024 quarter

Net profit of Jenburkt Pharmaceuticals rose 20.56% to Rs 6.51 crore in the quarter ended December 20

Read more

29 Jan 25

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Jenburkt Pharmaceuticals Ltd

What is the current PE Ratio of Jenburkt Pharmaceuticals Ltd?

The Current PE Ratio of Jenburkt Pharmaceuticals Ltd is 14.59 as on 2 May 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 39.9 as on 2 May 2025.

What was the PE Ratio of Jenburkt Pharmaceuticals Ltd last year?

The PE Ratio of Jenburkt Pharmaceuticals Ltd was 11.94 last year, now the PE ratio is 14.59, showing a year-on-year growth of 22.2%.

What does the PE Ratio of Jenburkt Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Jenburkt Pharmaceuticals Ltd is 14.59. This ratio indicates that investors are willing to pay 14.59 times the earnings per share for each share of Jenburkt Pharmaceuticals Ltd.

What is the PE Ratio Growth of Jenburkt Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Jenburkt Pharmaceuticals Ltd grew by 22.2% whereas, the EPS ratio grew by -32.2.

How does the PE ratio of Jenburkt Pharmaceuticals Ltd compare to industry peers?

The PE ratio of Jenburkt Pharmaceuticals Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Jenburkt Pharmaceuticals Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Jenburkt Pharmaceuticals Ltd PE Ratio.

What factors influence the PE ratio of Jenburkt Pharmaceuticals Ltd PE Ratio?

The PE ratio of Jenburkt Pharmaceuticals Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Jenburkt Pharmaceuticals Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Jenburkt Pharmaceuticals Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Jenburkt Pharmaceuticals Ltd PE Ratio?

You can check the latest PE ratio of Jenburkt Pharmaceuticals Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Jenburkt Pharmaceuticals Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Jenburkt Pharmaceuticals Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Jenburkt Pharmaceuticals Ltd PE Ratio predict future stock performance?

While the Jenburkt Pharmaceuticals Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions